Lyme Disease Testing
A Global Strategic Business Report
MCP31942
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (55)
3
CXO5
VICE PRESIDENT10
DIRECTOR25
MANAGER12
MARKETING
REQUEST FULL-STACK INDEX
Includes 350+ pages validated sources
QUESTIONNAIRE
EXECUTIVES
DATA ROOM
HIGHLIGHTS & REPORT INDEX
Global Lyme Disease Testing Market to Reach US$18.6 Billion by 2030
The global market for Lyme Disease Testing estimated at US$12.7 Billion in the year 2024, is expected to reach US$18.6 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. IGRA Testing Technology, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$12.4 Billion by the end of the analysis period. Growth in the Other Technologies segment is estimated at 9.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 6.5% CAGR
The Lyme Disease Testing market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.0 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.9% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.
Global Lyme Disease Testing Market – Key Trends & Drivers Summarized
Why Is Lyme Disease Testing Gaining Importance?
Lyme disease is one of the most common tick-borne illnesses, with cases rising due to climate change and increased outdoor activities in endemic areas. Early and accurate detection of Lyme disease is critical to preventing long-term complications such as neurological and joint issues. As public awareness of tick-borne diseases grows, the demand for advanced and reliable Lyme disease testing is increasing.
How Are Innovations Enhancing the Performance of Lyme Disease Testing?
Advancements in molecular diagnostics, serological assays, and rapid point-of-care testing are improving the accuracy and speed of Lyme disease diagnosis. Next-generation PCR-based tests can detect the Borrelia bacteria at an early stage, reducing false negatives associated with traditional antibody tests. AI-driven diagnostic tools and at-home test kits are also emerging, providing faster and more accessible testing solutions. Additionally, researchers are developing multi-target assays that can distinguish Lyme disease from other tick-borne illnesses.
What Are the Key Market Drivers?
The rising incidence of Lyme disease, increased public health initiatives, and technological advancements in diagnostic methods are key market drivers. Government agencies and research institutions are investing in better diagnostic tools to enable early detection and improve treatment outcomes. The growing trend of outdoor recreational activities and pet ownership has also heightened the need for Lyme disease awareness and testing.
What Challenges and Future Opportunities Exist?
Challenges include the variability in test accuracy, high costs of advanced diagnostic methods, and limited awareness in some regions. However, opportunities exist in developing AI-assisted Lyme disease detection tools, expanding at-home test kit availability, and integrating Lyme disease screening into routine wellness check-ups.
SCOPE OF STUDY
The report analyzes the Lyme Disease Testing market by the following Segments, and Geographic Regions/Countries:
Segments:
Technology (IGRA Testing Technology, Other Technologies); Test (Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test, Nucleic Acid Test); Sample (Blood Sample, Urine Sample, CSF Sample, Other Samples); End-Use (Hospitals End-Use, Diagnostic Laboratories End-Use, Other End-Uses).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..
SELECT PLAYERS
Abbott Laboratories; Affymetrix, Inc.; bioMérieux SA; Bio-Rad Laboratories, Inc.; Ceres Nanosciences; DiaSorin S.p.A; F. Hoffmann-La Roche AG; Galaxy Diagnostics; Gold Standard Diagnostics; Graphene Frontiers; IGeneX, Inc.; LabCorp; Meridian Bioscience, Inc.; Oxford Immunotec; Quest Diagnostics; Quidel Corporation; T2 Biosystems, Inc.; Thermo Fisher Scientific, Inc.; Trinity Biotech; ZEUS Scientific
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Lyme Disease Testing – Global Key Competitors Percentage Market Share in 2025 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 32 Players Worldwide in 2025 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Rising Global Incidence of Lyme Disease Throws the Spotlight on Early and Accurate Diagnostic Solutions |
| Increased Awareness of Tick-Borne Illnesses Spurs Demand for Preventive Testing and Screening Services |
| Expansion of Point-of-Care Testing Capabilities Enhances Accessibility in Rural and Underserved Areas |
| Advancements in Molecular and Serological Testing Methods Strengthen Diagnostic Accuracy and Speed |
| Growing Availability of At-Home Lyme Disease Test Kits Expands Direct-to-Consumer Market Opportunity |
| Government and NGO-Funded Public Health Campaigns Propel Testing Awareness and Uptake |
| Integration of Lyme Testing Into Routine Travel and Outdoor Health Checkups Increases Market Penetration |
| Increase in Outdoor Recreational Activities Post-Pandemic Drives Risk-Based Testing Demand |
| Regulatory Push for Standardization and Test Validation Improves Reliability Across Commercial Test Providers |
| Rising Clinical Interest in Co-Infections and Chronic Lyme Disease Supports Multi-Pathogen Testing Platforms |
| Insurance Coverage Expansion in North America Enhances Affordability and Uptake of Lyme Testing |
| Growth in Personalized and Preventive Medicine Accelerates Demand for Early Diagnostic Tools |
| Growing Concerns Over Misdiagnosis and Delayed Treatment Strengthen Business Case for Improved Test Accuracy |
| Adoption of AI and Predictive Analytics in Lab Testing Enhances Efficiency in Diagnosis and Reporting |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Lyme Disease Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030 |
| World Recent Past, Current & Future Analysis for Lyme Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Lyme Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Lyme Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for IGRA Testing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for IGRA Testing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for IGRA Testing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for CSF Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for CSF Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for CSF Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Blood Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Blood Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Blood Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Urine Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Urine Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Urine Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Serological Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Serological Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Serological Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Lymphocytic Transformation Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Lymphocytic Transformation Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Lymphocytic Transformation Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Urine Antigen Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Urine Antigen Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Urine Antigen Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Immunofluorescent Staining Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Immunofluorescent Staining Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Immunofluorescent Staining Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Nucleic Acid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Nucleic Acid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Nucleic Acid Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Lyme Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Lyme Disease Testing by Technology - Percentage Breakdown of Value Sales for IGRA Testing Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Lyme Disease Testing by Sample - Percentage Breakdown of Value Sales for CSF Sample, Other Samples, Blood Sample and Urine Sample for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Lyme Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Lyme Disease Testing by Test - Percentage Breakdown of Value Sales for Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Lyme Disease Testing by Technology - Percentage Breakdown of Value Sales for IGRA Testing Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Lyme Disease Testing by Sample - Percentage Breakdown of Value Sales for CSF Sample, Other Samples, Blood Sample and Urine Sample for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Lyme Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Lyme Disease Testing by Test - Percentage Breakdown of Value Sales for Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test for the Years 2015, 2025 & 2030 |
| JAPAN |
| Lyme Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Lyme Disease Testing by Technology - Percentage Breakdown of Value Sales for IGRA Testing Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Lyme Disease Testing by Sample - Percentage Breakdown of Value Sales for CSF Sample, Other Samples, Blood Sample and Urine Sample for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Lyme Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Lyme Disease Testing by Test - Percentage Breakdown of Value Sales for Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test for the Years 2015, 2025 & 2030 |
| CHINA |
| Lyme Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Lyme Disease Testing by Technology - Percentage Breakdown of Value Sales for IGRA Testing Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Lyme Disease Testing by Sample - Percentage Breakdown of Value Sales for CSF Sample, Other Samples, Blood Sample and Urine Sample for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Lyme Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Lyme Disease Testing by Test - Percentage Breakdown of Value Sales for Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test for the Years 2015, 2025 & 2030 |
| EUROPE |
| Lyme Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Lyme Disease Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Lyme Disease Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Lyme Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Lyme Disease Testing by Technology - Percentage Breakdown of Value Sales for IGRA Testing Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Lyme Disease Testing by Sample - Percentage Breakdown of Value Sales for CSF Sample, Other Samples, Blood Sample and Urine Sample for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Lyme Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Lyme Disease Testing by Test - Percentage Breakdown of Value Sales for Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test for the Years 2015, 2025 & 2030 |
| FRANCE |
| Lyme Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Lyme Disease Testing by Technology - Percentage Breakdown of Value Sales for IGRA Testing Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Lyme Disease Testing by Sample - Percentage Breakdown of Value Sales for CSF Sample, Other Samples, Blood Sample and Urine Sample for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Lyme Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Lyme Disease Testing by Test - Percentage Breakdown of Value Sales for Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test for the Years 2015, 2025 & 2030 |
| GERMANY |
| Lyme Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Lyme Disease Testing by Technology - Percentage Breakdown of Value Sales for IGRA Testing Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Lyme Disease Testing by Sample - Percentage Breakdown of Value Sales for CSF Sample, Other Samples, Blood Sample and Urine Sample for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Lyme Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Lyme Disease Testing by Test - Percentage Breakdown of Value Sales for Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Lyme Disease Testing by Technology - Percentage Breakdown of Value Sales for IGRA Testing Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Lyme Disease Testing by Sample - Percentage Breakdown of Value Sales for CSF Sample, Other Samples, Blood Sample and Urine Sample for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Lyme Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Lyme Disease Testing by Test - Percentage Breakdown of Value Sales for Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Lyme Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Lyme Disease Testing by Technology - Percentage Breakdown of Value Sales for IGRA Testing Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Lyme Disease Testing by Sample - Percentage Breakdown of Value Sales for CSF Sample, Other Samples, Blood Sample and Urine Sample for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Lyme Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Lyme Disease Testing by Test - Percentage Breakdown of Value Sales for Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Lyme Disease Testing by Technology - Percentage Breakdown of Value Sales for IGRA Testing Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Lyme Disease Testing by Sample - Percentage Breakdown of Value Sales for CSF Sample, Other Samples, Blood Sample and Urine Sample for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Lyme Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Lyme Disease Testing by Test - Percentage Breakdown of Value Sales for Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Lyme Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Lyme Disease Testing by Technology - Percentage Breakdown of Value Sales for IGRA Testing Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Lyme Disease Testing by Sample - Percentage Breakdown of Value Sales for CSF Sample, Other Samples, Blood Sample and Urine Sample for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Lyme Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Lyme Disease Testing by Test - Percentage Breakdown of Value Sales for Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test for the Years 2015, 2025 & 2030 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Lyme Disease Testing by Technology - IGRA Testing Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Lyme Disease Testing by Technology - Percentage Breakdown of Value Sales for IGRA Testing Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Lyme Disease Testing by Sample - CSF Sample, Other Samples, Blood Sample and Urine Sample Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Lyme Disease Testing by Sample - Percentage Breakdown of Value Sales for CSF Sample, Other Samples, Blood Sample and Urine Sample for the Years 2015, 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Lyme Disease Testing by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Lyme Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Lyme Disease Testing by Test - Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Lyme Disease Testing by Test - Percentage Breakdown of Value Sales for Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test and Nucleic Acid Test for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]